Invesaro

Stocks CVBF Financial statements

Financial statements

CVB FINANCIAL CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CVB FINANCIAL CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating income0.3314314314
Interest expense7.988.312.822.114.36.089.16118
Pre-tax income162189211291250298328315271282
Income tax60.984.459.183.272.485.192.99470.572.4
Net income101104152208177213235221201209
EBITDA14332329329
EPS, basic0.940.951.251.481.301.571.671.591.441.52
EPS, diluted0.940.951.241.481.301.561.671.591.441.52
Shares, basic (weighted)107109122140136135140138138137
Shares, diluted (weighted)108110122140136135140138139137
Dividend per share0.480.540.560.720.720.720.770.800.800.80

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents1221441641861,9581,733203281205376
Property, plant and equipment42.146.258.25451.149.146.744.727.526.5
Lease right-of-use assets18.519.119.322.721.747.143.8
Goodwill89.5117667664664664766766766766
Intangible assets5.016.8453.84333.625.421.715.39.975.77
Total assets8,0748,27111,52911,28214,41915,88416,47716,02115,15415,631
Accrued liabilities9.2
Short-term debt052.3995995
Lease liabilities21.421.220.924.524.149.646.5
Total liabilities7,0837,2019,6789,28812,41113,80214,52813,94312,96713,336
Paid-in capital5315731,2941,2991,2121,2101,3001,2891,2971,222
Retained earnings4494945766837618761,0031,1131,2011,301
Other comprehensive income10.21.45-18.312.635.3-3.97-355-324-312-228
Shareholders' equity9911,0691,8511,9942,0082,0821,9492,0782,1862,295
Total equity9911,0691,8511,9942,0082,0821,9492,0782,1862,295
Total liabilities and equity8,0748,27111,52911,28214,41915,88416,47716,02115,15415,631
Shares outstanding108110140140136136140139140136

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income101104152208177213235221201209
Depreciation and amortization5.322.668.3522-1.16-6.4313.718.215.414.8
Stock-based compensation2.82.953.515.555.535.187.99.4410.26.22
Deferred income tax1.7223.17.512.2-4.4413.1-3.27-4.344.171.8
Cash from operations125138165208185195274296250221
Capital expenditures-12.6-4.89-4.19-5.52-4.67-4.68-5.36-4.52-5.14-4.07
Acquisitions-7.528.3-13300032900
Purchases of investments-462-320-98.7-493-1,231-1,649-1,146-46.4-419-484
Sales and maturities of investments97.628.624.77.119.810.3390.20.3366.465
Cash from investing-154140811325-1,269-1,730-1,177536853-210
Stock issued5.152.681.72.220.231.281.920.210.570.38
Share buybacks-1.91-1.13-7.76-2.64-92.8-8.34-46.3-21.2-2.82-81.1
Dividends paid-51.6-57-66-95.4-98.5-97.7-104-112-112-111
Cash from financing45-256-956-5122,8561,310-626-754-1,179161
Net change in cash15.522.719.621.61,773-226-1,52977.8-76.6172
Free cash flow112134161203180191268291245217
Interest paid7.998.2913.221.213.66.018.5895.5200133
Income taxes paid51.570.348.969.373.669.988.969.953.833

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $22.53 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Effective tax rate25.3%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)6.5%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)1.0%Net income / average total assets.

Growth

MetricValueHow it is calculated
Operating income growth, 1y0.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y915.3%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y-0.2%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y186.6%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y4.3%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-3.8%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y3.4%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y5.6%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-3.1%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y3.2%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-11.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-6.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y3.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-11.2%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-6.8%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y3.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y1.3%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y2.1%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y5.0%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y5.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y2.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y3.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-1.7%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y1.6%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Liabilities / assets85.0%Total liabilities / total assets.
Goodwill and intangibles / assets5.7%(Goodwill + intangible assets) / total assets.
Tangible book value$1.95BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
FCF conversion276.7%Free cash flow / net income, when net income is positive.
Capex / operating cash flow0.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.24Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
FCF per share$3.42Free cash flow / diluted weighted shares.
Operating cash flow per share$3.45Cash from operations / diluted weighted shares.
Book value per share$17.98Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$11.07Tangible book value / shares outstanding.
Cash per share$6.27(Cash + short-term investments) / shares outstanding.
Payout ratio52.9%Dividends paid / net income, when net income is positive.
Dividends / FCF19.1%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF7.9%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$3.97BShare price x shares outstanding.
Enterprise value$2.86BMarket cap + total debt - cash - short-term investments.
P/E19.2xMarket cap / net income. Only when net income is positive.
P/B1.25xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book2.03xMarket cap / tangible book value, when positive.
P/FCF6.93xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF6.87xMarket cap / cash from operations, when positive.
EV/FCF5.00xEnterprise value / free cash flow, when both are positive.
FCF yield14.4%Free cash flow / market cap.
Earnings yield5.2%Net income / market cap (the inverse of P/E).
Dividend yield2.8%Dividends paid over the period / market cap.
Shareholder yield3.9%(Dividends paid + share buybacks) / market cap.
Was CVB FINANCIAL CORP profitable in fiscal 2025?

Yes. Net income was $209.3M, a net margin of -.

How much free cash flow did CVB FINANCIAL CORP generate in fiscal 2025?

Cash from operations of $221.4M minus capital expenditures of $4.1M left free cash flow of $217.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CVB FINANCIAL CORP